drugset / Trial / NCT02990403
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
RandomizedParallel-groupOpen-labelTreatment
Summary
In this clinical cohort study, the investigators are going to observe the efficacy of anti-coagulation and immune therapy in the treatment of recurrent pregnancy loss with a prospective randomized controlled trial.
Timeline
- Start
- 2014-10
- Primary completion
- 2017-06-10
- Completion
- 2018-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | Oral |
| Subject | Aspirin | Small molecule | 100 mg | Oral |
| Subject | Dydrogesterone | Other / unclassified | 20 mg | Oral |
| Subject | Dydrogesterone | Other / unclassified | 30 mg | Oral |
| Subject | Heparin | Other / unclassified | 4100 iu | Subcutaneous |
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 300 mg/kg | Intravenous |
| Subject | Prednisone | Other / unclassified | 5 mg | Oral |
| Subject | Prednisone | Other / unclassified | 10 mg | Oral |